Search Results

The National Directory of Mental Health Treatment Facilities - 2020 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2019 National Mental Health Services Survey (N-MHSS). The information about each facility that...

The National Directory of Mental Health Treatment Facilities - 2019 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2018 National Mental Health Services Survey (N-MHSS). The information about each facility that...

This report presents national- and state-level data from the Treatment Episode Data Set (TEDS) for admissions and discharges occurring in 2017, and trend data from 2007 to 2017. It summarizes demographic information and the characteristics and outcomes of treatment for alcohol and/or drug use among clients aged 12 years and...

This short report uses data from the Drug Abuse Warning Network (DAWN) to examine the emergency department (ED) visits for children aged 1 -5 that involved opioid pain relievers. Hydrocodone (Vicodin, Lortab), oxycodone (OxyContin, Percocet), and codeine are examples of opioid pain relievers; buprenorphine (Suboxone), is an opioid that is...

This report presents results from the 2016 National Survey on Drug Use and Health (NSDUH) for people aged 12 or older regarding the perceived harmfulness of using cigarettes, alcohol, and specific illicit drugs as well as the perceived availability of substances. Estimates are presented for specific age groups. Estimates of...

This report summarizes methods and other supporting information that are relevant to estimates of substance use and mental health issues from the 2015 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. Section...

The purpose of this report is to describe the differences between the DSM-IV and DSM-5 diagnostic criteria that could affect national estimates of childhood serious emotional disturbance (SED). The report also provides a description of DSM-5 updates
that have been made (or are being made) to existing diagnostic instruments and...

This report summarizes methods and other supporting information that are relevant to estimates of substance use and mental health issues from the 2014 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. This...

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables. The URS is a state, national, and territories reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization...

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network to examine the trends in ED visits involving methamphetamine from 2007 to 2011. In addition to the trends for total methamphetamine-related visits, it also shows trends by gender and by age group; the...

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving...

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,